Nicotinamide Idi (Nicotinamide)

Nicotinamide is used to address conditions related to niacin deficiency and skin health, as well as general nutritional needs.

• Niacin deficiency: helps restore normal levels of vitamin B3 and prevents symptoms such as pellagra.
• Skin health: supports barrier function and may improve appearance of dry or inflamed skin.
• General nutritional supplementation: provides an essential nutrient for metabolic processes in individuals with inadequate dietary intake.

• Nicotinamide acts as a precursor for nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in redox reactions, DNA repair, and cellular signaling. After oral absorption, it is converted to NAD+ in tissues, supporting energy metabolism, enzymatic activity of dehydrogenases, and the function of sirtuins, thereby contributing to normal cellular function and skin integrity. The increased NAD+ pool also influences oxidative stress responses and helps maintain healthy keratinocyte turnover.

Oral nicotinamide is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects

• Nausea: mild stomach upset that usually resolves without intervention, may be lessened by taking with food.
• Headache: transient headache reported in a minority of users, often mild and short‑lasting.
• Flushing: occasional mild flushing similar to that seen with niacin, typically brief and not painful.
• Gastrointestinal discomfort: abdominal cramps, diarrhea or loose stools that generally improve with continued use.
• Skin irritation: mild rash or itching at the site of contact, usually resolves after discontinuation.

Serious or Rare Side Effects

• Hepatotoxicity: elevated liver enzymes or liver injury in rare cases, requiring monitoring of hepatic function.
• Severe hypersensitivity: anaphylactic reactions with swelling, difficulty breathing, and hives, needing immediate medical care.
• Blood disorders: rare cases of thrombocytopenia or leukopenia, presenting with easy bruising or infections.
• Metabolic acidosis: extremely rare, associated with very high doses, presenting with rapid breathing and fatigue.
• Hyperuricemia: possible increase in uric acid levels leading to gout flare, especially in predisposed individuals.

When using Nicotinamide Idi, certain precautions should be observed to ensure safety and product integrity.

• Assess renal function: adjust use in patients with severe renal impairment.
• Monitor liver enzymes: periodic testing is advised for long‑term high‑dose therapy.
• Avoid excessive alcohol: concurrent heavy alcohol intake may increase liver risk.
• Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited.
• Drug interactions: review concomitant medications for potential interactions (see interaction section).
• Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Nicotinamide may affect the pharmacokinetics or pharmacodynamics of several medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

• Anticonvulsants (e.g., carbamazepine, phenobarbital): may reduce nicotinamide efficacy by increasing metabolism.
• High‑dose vitamin B3 (niacin) supplements: combined use can increase risk of liver toxicity.
• Chemotherapeutic agents (e.g., methotrexate): potential additive toxicity to liver.

Moderate Interactions (Monitor Closely)

• Antihypertensives: nicotinamide may modestly lower blood pressure, requiring dose adjustment.
• Antidiabetic drugs: possible enhancement of hypoglycemic effect, monitor glucose levels.
• Oral anticoagulants: may affect platelet function, monitor INR or clotting parameters.